Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Marks

Showing results (431-440 of 683) with videos related to

Pageof 69
Sort By:
Cancer|March 7, 2018
Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemiaHagop M Kantarjian, Yun Su, Elias J Jabbour, et al.
Investigative Radiology|January 1, 1991
Pre- to postnatal reduction in ultrasound attenuation coefficient of the liverP L Carson, E H Chiang, J M Rubin, et al.
Expert Review of Hematology|May 21, 2025
Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: a plain language summaryDavid I Marks, Ryan D Cassaday, Josep-Maria Ribera, et al.
Leukemia & Lymphoma|October 4, 2019
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use dataCatherine S Y Lecat, Caroline Besley, Rachael E Hough, et al.
Cancer Genetics and Cytogenetics|May 1, 1995
Translocation 11;14 in newly diagnosed chronic myelogenous leukemiaA Magdalinski, H Drwinga, P Crilley, et al.
Expert Review of Hematology|January 8, 2025
Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature reviewDavid I Marks, Ryan D Cassaday, Josep-Maria Ribera, et al.
Anxiety|January 1, 1996
Cardio-respiratory and other symptom clusters in panic disorderB Bandelow, M Amering, O Benkert, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2013
Recovery of a top predator mediates negative eutrophic effects on seagrassBrent B Hughes, Ron Eby, Eric Van Dyke, et al.
American Journal of Clinical Oncology|December 10, 2020
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing RegimensEric I Marks, Robert Matera, Adam J Olszewski, et al.
Bone Marrow Transplantation|May 13, 1998
Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantationV L Grandage, J M Cornish, D H Pamphilon, et al.
Pageof 69

Showing results (431-440 of 683) with videos related to

Sort By:
Pageof 69
Cancer|March 7, 2018
Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemiaHagop M Kantarjian, Yun Su, Elias J Jabbour, et al.
Investigative Radiology|January 1, 1991
Pre- to postnatal reduction in ultrasound attenuation coefficient of the liverP L Carson, E H Chiang, J M Rubin, et al.
Expert Review of Hematology|May 21, 2025
Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: a plain language summaryDavid I Marks, Ryan D Cassaday, Josep-Maria Ribera, et al.
Leukemia & Lymphoma|October 4, 2019
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use dataCatherine S Y Lecat, Caroline Besley, Rachael E Hough, et al.
Cancer Genetics and Cytogenetics|May 1, 1995
Translocation 11;14 in newly diagnosed chronic myelogenous leukemiaA Magdalinski, H Drwinga, P Crilley, et al.
Expert Review of Hematology|January 8, 2025
Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature reviewDavid I Marks, Ryan D Cassaday, Josep-Maria Ribera, et al.
Anxiety|January 1, 1996
Cardio-respiratory and other symptom clusters in panic disorderB Bandelow, M Amering, O Benkert, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2013
Recovery of a top predator mediates negative eutrophic effects on seagrassBrent B Hughes, Ron Eby, Eric Van Dyke, et al.
American Journal of Clinical Oncology|December 10, 2020
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing RegimensEric I Marks, Robert Matera, Adam J Olszewski, et al.
Bone Marrow Transplantation|May 13, 1998
Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantationV L Grandage, J M Cornish, D H Pamphilon, et al.
Pageof 69